Here are the latest quarterly results of Procter & Gamble Health. For more details, see the Procter & Gamble Health financial fact sheet and Procter & Gamble Health share price and chart. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-19 |
3
Jun-19 |
3
Sep-19 |
3
Dec-19 |
3
Mar-20 |
3
Jun-20 |
3
Sep-20 |
3
Dec-20 |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 2,310 | 2,336 | 2,252 | 2,368 | 2,281 | 6,345 | 10,095 | 10,184 | |
Other income | Rs m | 177 | 175 | 67 | 61 | 103 | 96 | 96 | 94 | |
Turnover | Rs m | 2,487 | 2,511 | 2,319 | 2,428 | 2,384 | 6,441 | 10,190 | 10,278 | |
Expenses | Rs m | 1,809 | 1,791 | 1,753 | 1,877 | 1,694 | 5,242 | 6,712 | 6,760 | |
Gross profit | Rs m | 501 | 545 | 499 | 490 | 587 | 1,103 | 3,383 | 3,424 | |
Depreciation | Rs m | 43 | 45 | 40 | 43 | 42 | 132 | 118 | 120 | |
Interest | Rs m | 0 | 0 | 0 | 0 | 0 | 10 | 4 | 21 | |
Profit before tax | Rs m | 635 | 675 | 526 | 508 | 648 | 1,056 | 3,357 | 3,377 | |
Tax | Rs m | 228 | 234 | 168 | 126 | 183 | 364 | 818 | 871 | |
Profit after tax | Rs m | 407 | 441 | 358 | 382 | 465 | 692 | 2,539 | 2,506 | |
Gross profit margin | % | 21.7 | 23.3 | 22.2 | 20.7 | 25.8 | 17.4 | 33.5 | 33.6 | |
Effective tax rate | % | 35.9 | 34.7 | 32.0 | 24.8 | 28.3 | 34.5 | 24.4 | 25.8 | |
Net profit margin | % | 17.6 | 18.9 | 15.9 | 16.1 | 20.4 | 10.9 | 25.1 | 24.6 | |
Diluted EPS | Rs | 24.5 | 26.6 | 21.5 | 23.0 | 28.0 | 41.7 | 152.9 | 151.0 | |
Diluted EPS (TTM) | Rs | 77.2 | 84.0 | 80.7 | 95.6 | 99.1 | 114.2 | 245.6 | 373.6 | |
![]() |
Read: Procter & Gamble Health 1QFY21 Result Performance Review
More Pharmaceuticals Company Quarterly Results: INDRAPRASTHA MEDICAL FULFORD INDIA BIOCON NATCO PHARMA FRESENIUS KABI ONCO.
Compare PROCTER & GAMBLE HEALTH With: INDRAPRASTHA MEDICAL FULFORD INDIA BIOCON NATCO PHARMA FRESENIUS KABI ONCO.
Compare PROCTER & GAMBLE HEALTH With: ACTAVIS (US) MYLAN (US) ADCOCK INGRAM (S. Africa) TEVA PHARMA (Israel)
Indian share markets witnessed volatile trading activity throughout the day today and ended lower.
CIPLA share price has hit an all time high at Rs 966 (up 0.6%). The BSE HEALTHCARE Index is up by 1.1%. Among the top gainers in the BSE HEALTHCARE Index today are CIPLA (up 0.6%) and ABBOTT INDIA (up 1.1%). The top losers include PROCTER & GAMBLE HEALTH (down 0.3%) and BIOCON (down 0.3%).
For the quarter ended June 2020, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 692 m (up 57.0% YoY). Sales on the other hand came in at Rs 6 bn (up 171.6% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.
For the quarter ended September 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 358 m (down 13.0% YoY). Sales on the other hand came in at Rs 2 bn (down 0.4% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.
Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.
More Views on NewsAjit Dayal on how India's vaccine strategy will impact the markets.
Narayana Murthy was one of the first unicorn founders to get the backing of this entity...
There is no stopping this 11-bagger stock from significant upside.
In this video I tell you the three Nifty ETFs I think are the best.
In this video, I'll you what I think is the real reason behind yesterday's market crash.
More